Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LEVETIRACETAM USP (PROCESS II), with a corresponding US DMF Number 23853.
Remarkably, this DMF maintains an Active status since its submission on June 02, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 21, 2013, and payment made on May 14, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II